Integra LifeSciences suspends new patient enrollment in the clinical trial for DuraGen Plus Adhesion Barrier Matrix in spinal surgery

By

    
 Integra announced that it will suspend the enrollment of new patients in the clinical trial for DuraGen Plus® Adhesion Barrier Matrix for evaluating the safety and effectiveness as an adhesion barrier in spinal surgery.
SEC Filing…  http://ow.ly/DcPs
...

Your friends are reading OrthoStreams daily - Are you ?

 

Unlock your access to full rich article, trends, hot startups, market reports and your daily newsletter.

Just $1/day.